Immunological and clinical consequences of treating a patient with natalizumab

Multiple Sclerosis Journal

Volumn 18, Issue 3, 2012, Pages 335-344

  Schwab, Nicholas ^a,b   Höhn, Karin G ^a,b   Schneider Hohendorf, Tilman ^a,b   Metz, Imke ^c   Stenner, Max Philipp ^b,g   Jilek, Samantha ^d   Du Pasquier, Renaud A ^d   Gold, Ralf ^e   Meuth, Sven G ^a,c   Ransohoff, Richard M ^f   Brück, Wolfgang ^c   Wiendl, Heinz ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f LERNER RESEARCH INSTITUTE   (United States)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

antibodies (monoclonal); immune reconstitution inflammatory syndrome; JC virus; multiple sclerosis; progressive multifocal leukoencephalopathy

Indexed keywords

ALPHA4 INTEGRIN; BETA1A INTERFERON; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CIDOFOVIR; CORTICOSTEROID; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MEFLOQUINE; MIRTAZAPINE; MITOXANTRONE; NATALIZUMAB; T LYMPHOCYTE RECEPTOR;

ADULT; ALEXIA; ANTIGEN EXPRESSION; ARTICLE; BRAIN BIOPSY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; EXPANDED DISABILITY STATUS SCALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOADSORPTION; IMMUNOHISTOLOGY; JC VIRUS; LYMPHOCYTE MIGRATION; MALE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; T LYMPHOCYTE; VIRUS LOAD;

EID: 84857887383     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511421919     Document Type: Article

References (30)

1. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992 ; 356: 63-66
2. Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue E-W, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med. 2006 ; 354: 911-923
3. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006 ; 354: 899-910
4. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. 2009 ; 361: 1075-1080
5. Ransohoff RM. Natalizumab and PML. Nat Neurosci. 2005 1275 ; 8 :
6. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?. Ann Neurol. 2006 ; 60: 162-173 (Pubitemid 44182391)
7. Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol. 2010 ; 68: 295-303
8. Huang Y-H, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, et al. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann Neurol. 2009 ; 66: 171-183
9. Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J Immunol. 2010 ; 184: 5368-5374
10. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, Hay JB, et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. 2005 ; 6: 889-894 (Pubitemid 43090443)
11. Lee BP, Imhof BA. Lymphocyte transmigration in the brain: a new way of thinking. Nat Immunol. 2008 ; 9: 117-118
12. Wiendl H, Malotka J, Holzwarth B, Weltzien HU, Wekerle H, Hohlfeld R, et al. An autoreactive gamma delta TCR derived from a polymyositis lesion. J Immunol. 2002 ; 169: 515-521 (Pubitemid 34686174)
13. Seitz S, Schneider CK, Malotka J, Nong X, Engel AG, Wekerle H, et al. Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues. Proc Natl Acad Sci U S A. 2006 ; 103: 12057-12062 (Pubitemid 44215810)
14. Schwab N, Bien CG, Waschbisch A, Becker A, Vince GH, Dornmair K, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain. 2009 ; 132: 1236-1246
15. Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology. 2009 ; 72: 402-409
16. Schröder A, Lee D-H, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. 2010 ; 67: 1391-1394
17. Stenner MP, Waschbisch A, Buck D, Doerck S, Einsele H, Toyka KV, et al. Effects of natalizumab treatment on Foxp3+ T regulatory cells. PLoS ONE. 2008 ; 3: e3319
18. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer. 2003 ; 105: 186-189 (Pubitemid 36505319)
19. Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003 ; 9: 3406-3412 (Pubitemid 37082736)
20. Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002 ; 62: 2937-2941 (Pubitemid 34525782)
21. Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell Immunol. 2006 ; 243: 19-29
22. Niino M, Bodner C, Simard ML, Alatab S, Gano D, Kim HJ, et al. Natalizumab effects on immune cell responses in multiple sclerosis. Ann Neurol. 2006 ; 59: 748-754 (Pubitemid 43673152)
23. Du Pasquier RA, Clark KW, Smith PS, Joseph JT, Mazullo JM, De Girolami U, et al. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol. 2001 ; 7: 318-322 (Pubitemid 32894235)
24. Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 ; 127: 1970-1978 (Pubitemid 39150256)
25. Rose DM, Han J, Ginsberg MH. Alpha4 integrins and the immune response. Immunol Rev. 2002 ; 186: 118-124
26. Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2005 ; 11: 16-22
27. Miralles P, Berenguer J, Lacruz C, Cosín J, López JC, Padilla B, et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS. 2001 ; 15: 1900-1902 (Pubitemid 32939260)
28. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol. 2005 ; 109: 449-455 (Pubitemid 40637320)
29. Richardson-Burns SM, Kleinschmidt-DeMasters BK, DeBiasi RL, Tyler KL. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol. 2002 ; 59: 1930-1936 (Pubitemid 35424652)
30. Kuhlmann T, Lassmann H, Brück W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol. 2008 ; 115: 275-287